M. de Krijger

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

N. Mostafavi, G. Meijer, E. Dekker, 2022, Inflammatory bowel diseases.

Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease

W. D. de Jonge, C. Ponsioen, G. Hooijer, 2020, Journal of translational autoimmunity.

Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease

W. D. de Jonge, R. Prinjha, P. Mander, 2021, Journal of Crohn's & colitis.

Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study

P. Schirmacher, R. Chapman, C. Sempoux, 2017, Hepatology.

Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis.

W. D. de Jonge, C. Ponsioen, M. Wildenberg, 2019, Journal of hepatology.

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis

W. D. de Jonge, C. Ponsioen, E. Levin, 2022, Frontiers in Immunology.

Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis

C. Ponsioen, S. Hübscher, D. Thorburn, 2021, Liver international : official journal of the International Association for the Study of the Liver.

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.

W. D. de Jonge, G. D'Haens, P. Moerland, 2019, Inflammatory bowel diseases.

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

A. Bergquist, R. Chapman, J. Boyer, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.